$7.43
0.354.94%
마지막 업데이트: Aug 19, 12:03 PM
Benzinga
Benzinga
Benzinga
수요일, 8월 19
Capricor Therapeutics Inc
CAPRNASDAQ
실적: Q2 2026 실적이 목 8월 13th에 시장 마감 후 발표되었습니다.
Capricor Therapeutics Earnings & Forecasts
Capricor Therapeutics (CAPR) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Capricor Therapeutics Guidance
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.58 | $-0.54 | $-0.53 | $-0.54 |
| Actual | $-0.70 | $-0.59 | $-0.62 | $-0.54 |
| Surprise | -20.7% | -9.26% | -17.0% | 0.00% |
| Revenue | ||||
| Estimate | — | $25.2M | $1.7M | $1.2M |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | -100.0% | -100.0% | -100.0% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.43 | $-0.03 | $-0.40 | $-0.37 |
| Revenue | ||||
| Consensus | $10.4M | $22.0M | — | — |
Earnings & Guidance News
Benzinga
© 2026 Benzinga | All Rights Reserved